Flick Gocke Schaumburg has advised the Printus group on the deal. McDermott Will & Emery LLP The Printus group is acquiring a 70 percent stake in...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Door2Door GmbH on the deal. Berlin-based mobility start-up Door2Door GmbH announced the sale of all shares in the company to Dubai-based...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Spine Biopharma in the transaction. Spine Biopharma, Inc, a biopharmaceutical company committed to developing non-opiate, non-surgical therapies for the treatment of...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Main Capital Partners on the acquisition of Audimex AG by Main portfolio company Blika Solutions AB. The sellers are Audimex founders...
You must be a Standard 1 Year member to access this content.
King & Wood Mallesons advised the shareholders of Cryptshare AG on the sale of their shares to the Swedish Pointsharp Group. McDermott Will & Emery and...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Vistra on the matter. Mori Hamada & Matsumoto advised on Japanese law. Vistra acted as Issuer across eight pre 2008 legacy Lehman...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery has advised Five Arrows Direct Lending on the financing of Oryx Group’s shareholder restructuring through a new leveraged transaction. The Oryx Group...
You must be a Standard 1 Year member to access this content.
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised Andera Partners with a team including Gr?oire Andrieux (Corporate M&A), Pierre-Arnoux...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery and Pier11 advised Ampersand Capital Partners on the deal. Ampersand Capital Partners announced the acquisition of a minority stake in BioEcho Life...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Ampersand Capital Partners in the transaction. Ampersand Capital Partners, a healthcare-focused private equity fund, and KKR, a leading global investment firm, finalized...
You must be a Standard 1 Year member to access this content.
King & Wood Mallesons advised Kither Biotech, while McDermott Will & Emery advised the investors on the deal. Kither Biotech, an Italian biopharmaceutical company developing novel...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery has advised the Nov Santé Actions Non Cotées fund on the deal. Nov Santé Actions Non Cotées fund, managed by Eurazeo and dedicated...
You must be a Standard 1 Year member to access this content.
